Editor's Choice
3 Results
- Article
Comparison of predictive models for cumulative live birth rate after treatment with ART
Reproductive BioMedicine OnlineVol. 45Issue 2p246–255Published online: March 31, 2022- Léna Bardet
- Jean-Baptiste Excoffier
- Noemie Salaun-Penquer
- Matthieu Ortala
- Maud Pasquier
- Emmanuelle Mathieu d'Argent
- and others
Cited in Scopus: 0Can a machine learning model better predict the cumulative live birth rate for a couple after intrauterine insemination or embryo transfer than Cox regression based on their personal characteristics? - Article
Intended parents' motivations and information and support needs when seeking extraterritorial compensated surrogacy
Reproductive BioMedicine OnlineVol. 31Issue 5p689–696Published online: August 21, 2015- Karin Hammarberg
- Martyn Stafford-Bell
- Sam Everingham
Cited in Scopus: 17Cross-border reproductive care (CBRC) is becoming increasingly common. Little is known about the motivations and information and support needs of people who cross borders to access surrogacy. This study aimed to explore: how those considering or undertaking extraterritorial surrogacy reach their decision; what other avenues they have considered and tried to have children; their sources of information and support; and perceptions of how others view their decision. Members of two Australian parenting support forums completed an anonymous online survey. - CommentaryOpen Access
Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited
Reproductive BioMedicine OnlineVol. 29Issue 6p659–661Published online: September 5, 2014- Rebecca Moffat
- Paul Pirtea
- Vanessa Gayet
- Jean Philippe Wolf
- Charles Chapron
- Dominique de Ziegler
Cited in Scopus: 34Ovarian stimulation improves assisted reproductive technology outcome by increasing the number of oocytes available for insemination and in-vitro handling. A recent Duplex protocol features a dual stimulation, with the second stimulation started immediately after the first oocyte retrieval. Remarkably, the Duplex protocol is unexpectadly well tolerated by women and provides twice as many oocytes and embryos as a regular antagonist protocol in less than 30 days.